Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Ozempic vs Retatrutide

Editorial comparison of Ozempic (semaglutide) and Retatrutide (retatrutide). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionOzempicRetatrutide
Generic namesemaglutideretatrutide
ManufacturerNovo NordiskEli Lilly
FDA approved2017
MechanismSame mechanism as Wegovy — GLP-1 receptor agonist.Where semaglutide hits one receptor and tirzepatide two, retatrutide adds a third: the glucagon receptor.
Dosing0.25mg weekly for 4 weeks, then 0.5mg, then 1mg, max 2mg. Lower max dose than Wegovy (2.4mg).Investigational. Trial dosing is once-weekly subcutaneous injection with gradual titration; final approved doses are not set.
CostList price ~$900-1,000/month.No commercial price exists. Available only via clinical-trial enrollment. Beware any website selling 'retatrutide' today, it is not a legal product.
Pivotal trial result1.4–1.8% HbA1c reduction across SUSTAIN trials (1.0 mg dose)~24% mean body-weight reduction at 48 weeks (highest dose, Phase 2)

Full Ozempic review →

FDA-approved semaglutide for type 2 diabetes. Widely used off-label for weight loss.

Full Retatrutide review →

Investigational triple agonist (GLP-1 / GIP / glucagon). Phase 3 weight loss approached ~24%, the highest yet. Not FDA-approved; expected 2027.

Frequently asked

Is Ozempic or Retatrutide more effective?+

In their pivotal trials, Ozempic reported 1.4–1.8% HbA1c reduction across SUSTAIN trials (1.0 mg dose), while Retatrutide reported ~24% mean body-weight reduction at 48 weeks (highest dose, Phase 2). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Ozempic and Retatrutide compare on cost?+

Ozempic: List price ~$900-1,000/month. Diabetes coverage is generally better than weight-loss coverage — many insurance plans cover Ozempic with a T2D diagnosis at standard copay. Retatrutide: No commercial price exists. Available only via clinical-trial enrollment. Beware any website selling 'retatrutide' today, it is not a legal product. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Ozempic to Retatrutide?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Ozempic and Retatrutide the same drug?+

No. Ozempic (semaglutide) and Retatrutide (retatrutide) are distinct medications from Novo Nordisk and Eli Lilly respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.